News
TFX
136.40
+0.49%
0.67
Weekly Report: what happened at TFX last week (0706-0710)?
Weekly Report · 19h ago
Intuitive, Globus, Teleflex named top picks as BMO initiates MedTech on buying opportunity
Seeking Alpha · 4d ago
Teleflex Price Target Announced at $159.00/Share by BMO Capital
Dow Jones · 4d ago
Teleflex Initiated at Outperform by BMO Capital
Dow Jones · 4d ago
BMO Capital Initiates Coverage On Teleflex with Outperform Rating, Announces Price Target of $159
Benzinga · 4d ago
Teleflex initiated with an Outperform at BMO Capital
TipRanks · 5d ago
Is Teleflex (TFX) Quietly Recasting Its Interventional Cardiology Ambitions Through the BIOMAG Trials?
Simply Wall St · 6d ago
Teleflex Publishes 2025 Global Impact Report
Barchart · 07/07 05:30
Weekly Report: what happened at TFX last week (0629-0703)?
Weekly Report · 07/06 10:29
Teleflex (TFX) Starts BIOMAG III As Freesolve Progress Tests Its Fair Value Story
Simply Wall St · 07/05 14:30
Weekly Report: what happened at TFX last week (0622-0626)?
Weekly Report · 06/29 10:23
Should Teleflex’s Bioresorbable Scaffold Trial Progress Require Action From Teleflex (TFX) Investors?
Simply Wall St · 06/29 00:20
Teleflex (TFX) Could Be 43% Undervalued Following BIOMAG III Study Enrollment
Simply Wall St · 06/27 22:12
Do Options Traders Know Something About Teleflex Stock We Don't?
NASDAQ · 06/24 15:35
Teleflex Initiates Enrollment In BIOMAG-III Trial For Freesolve RMS; BIOMAG-I Yields Promising Data
NASDAQ · 06/23 17:21
Teleflex begins enrollment in BIOMAG-III Study
TipRanks · 06/23 11:23
Teleflex Starts Enrollment For Its BIOMAG‑IIII Study Evaluating The Freesolve Resorbable Magnesium Scaffold
Benzinga · 06/23 10:34
Teleflex Initiates Enrollment in Global BIOMAG™‑III Pivotal Trial of Freesolve™ Resorbable Magnesium Scaffold
Barchart · 06/23 05:30
Weekly Report: what happened at TFX last week (0615-0619)?
Weekly Report · 06/22 10:34
How Investors Are Reacting To Teleflex (TFX) $500 Million 5.875% Senior Notes To Fund Transformation
Simply Wall St · 06/21 02:23
More
Webull provides a variety of real-time TFX stock news. You can receive the latest news about Teleflex Inc through multiple platforms. This information may help you make smarter investment decisions.
About TFX
Teleflex Incorporated is a global provider of medical technologies. The Company offers a diverse portfolio with solutions in the therapy areas of anesthesia, emergency medicine, interventional cardiology and radiology, surgical, vascular access, and urology. It primarily designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for common diagnostic and therapeutic procedures in critical care and surgical applications. It operates in three segments: the Americas, EMEA (Europe, the Middle East and Africa) and Asia (Asia Pacific). Its vascular access product portfolio includes Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous (bone access) systems. Its interventional product offerings consist of a portfolio of Arrow branded intra-aortic balloon pumps and catheters, GuideLiner, Turnpike and TrapLiner catheters, Pulsar-18 T3 Self-Expanding 4F Stent and Orsiro Mission Drug Eluting Stent.